• LOGIN
  • CONTACT US
  • enEnglish (English)
    • deDeutsch (German)
    • esEspañol (Spanish)
    • zh-hans简体中文 (Chinese (Simplified))
    • ja日本語 (Japanese)
    • pt-brPortuguês (Portuguese (Brazil))
    • heעברית (Hebrew)
    • ko한국어 (Korean)
    • frFrançais (French)
Arazy Group Consultants Inc.
  • Regulatory Solutions
    • LICENSALE®
    • REGISLATE®
    • Choose Your Regulatory Solution
    • Cost and Savings
    • European Regulatory Representative Services
  • 140 Countries
  • Resources
  • About Us
    • Webinars
    • Careers
Select Page

Certain Medical Devices in India will be Considered as Drugs as of 30 June 2022

by arazygroup | Nov 22, 2021 | Blog, Top Story Slider | 0 comments

By Fajar Dumadi | November 23, 2021

On February 8, 2019, the Ministry of Health & Family Welfare, Government of India, has notified that the following devices were regulated as drugs; effective from April 1, 2021:

  • All implantable medical devices
  • CT scan equipment
  • MRI equipment
  • Defibrillators
  • PET equipment
  • Dialysis machine
  • X-Ray machine
  • Bone marrow cell separator

However, due to there being a lot of procedural work to implement such a policy, the stakeholders requested an extension. Therefore, through its notification (1) in April 18, 2021, the Ministry of Health has extended the timeline to implement the policy for another 3 to 6 months.

On November 3, 2021, COVID-19 has further disrupted the implementation of the policy. Therefore, in order to ensure smooth transition, continuity of supply chain, and access to the patients, the Ministry of Health has decided that (2):

  • Import/manufacturing licenses for such devices must be obtained by or before June 30, 2022. The importer/manufacturer will be required to print the import/manufacturing license number on the label, effective from July 1, 2022.
  • For the existing importer/manufacturer who is already importing /manufacturing any of those devices, and whose application has been submitted to the Central License Authority or State License Authority, the said application is deemed to be valid. The importer/manufacturer can continue to import/manufacture the said device(s) up to June 30, 2022, or till the time the Central License Authority or State License Authority (as the case may be) takes a decision on the said application, whichever is earlier.
  • The applicants whose application was submitted by or before April 18, 2021 and considered as incomplete, is required to ensure submission of all the necessary documents to the concerned Authority by March 31, 2022.

Contact Us

Arazy Group has over 26 years of regulatory expertise in medical devices and IVD devices.

Contact us at [email protected] for any inquiries or regulatory assistance.

D

Search

Recent Posts

  • Malaysia – July 2022
  • Pakistan – July 2022
  • South Africa – June 2022
  • La Technologie des Dispositifs Médicaux
  • The Philippines- June 2022
  • Singapore- April 2022
  • Indonesia- March 2022
  • Malaysia- march 2022
  • The Philippines- Feb 2022
  • Malaysia Update – January 2022

Recent Comments

    Archives

    Categories

    • Application
    • Blog
    • Case Study
    • Documents
    • Homepage
    • Product Demo
    • Product Demo Slider
    • Products
    • Recent Registrations
    • Regulatory News
    • Regulatory News Slider
    • Regulatory Update
    • Regulatory Update Slider
    • Support
    • Top Story Slider
    • Uncategorized
    • Videos

    Arazy Group Consultants Inc. is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

    Regulatory Solutions

    • LICENSALE
    • REGISLATE
    • European Regulatory Representative Services
    • Resources
    • Privacy Policy
    • ISO 9001 Certificate

    Head Office

    #200-1333 Johnston St., Granville Island,
    Vancouver, BC V6H 3R9

    PHONE: +1 604.681.6888
    FAX: +1 604.681.6822
    [email protected]

    © Arazy Group Consultants Inc. - is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets
    ???

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Arazy Group Consultants Inc.
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    Security_overview - Privacy Policy